Transporter

Dopamine transporter

Sodium-dependent dopamine transporter

The dopamine transporter carries dopamine into the cell, driven by sodium. The human transporter was cloned from the substantia nigra, its gene lies on chromosome 5, and cocaine and amphetamine block its uptake of dopamine.1 In rat brain, antibodies showed the transporter in the cell bodies and in the terminal fields of the dopamine neurons of the midbrain. It was densest in the dorsal and ventral striatum, the nucleus accumbens and the olfactory tubercle, and less concentrated in the globus pallidus, the entopeduncular nucleus and the medial forebrain bundle. In the striatum it was enriched in patches. The noradrenergic locus coeruleus and the serotonergic raphe nuclei showed no labelling, and destroying the dopamine pathway on one side abolished the labelling in the striatum and cingulate cortex.2 Where the transporter is scarce, other transporters clear dopamine. In the frontal cortex of mice, dopamine uptake into nerve terminals was blocked by cocaine and by nisoxetine, an inhibitor of the noradrenaline transporter, but not by the DAT inhibitor GBR12909. In the caudate and the nucleus accumbens, uptake depends mainly on the dopamine transporter. Which transporter clears dopamine in a region depends on both the affinities and the local densities of the transporters.3

In rats, the potency of cocaine-like drugs in self-administration followed their binding to the dopamine transporter, and not their binding to a large number of other sites in the brain.4 In experienced cocaine users, at least 47 percent of the transporters had to be blocked before users perceived the effects of cocaine.5

A review of addictive drugs names three main factors that drive striatal dopamine, namely neuronal firing, reuptake through this transporter and the state of the presynaptic terminal. Cocaine acts by inhibiting reuptake, other drugs act by enhancing firing or by changing release from the terminal. The common principle is that each drug raises synaptic dopamine in a way that is detached from the normal drive by environmental cues.6

Mice without the transporter are hyperactive, dopamine stays outside their cells at least 100 times longer, and cocaine and amphetamine no longer change their activity.7 These mice are a genetic model of persistent functional hyperdopaminergia. Without the transporter no other mechanism keeps the extracellular dopamine in check, and the levels of the postsynaptic D1 and D2 receptors are downregulated.8 Amphetamine needs the transporter to release dopamine. In mice lacking it, amphetamine no longer raised dopamine outside the cells, while in normal mice it rose about tenfold.9 Amphetamine also acts at the vesicles. In cultured midbrain dopamine neurons it rapidly reduced the pH gradient across the vesicle membrane, and in isolated chromaffin granules this reduced the uptake and increased the release of transmitter. A later review describes how amphetamines combine several effects to release dopamine by reverse transport, independent of exocytosis and of normal firing.10,6

In a PET study of ten healthy men, modafinil at doses used in treatment blocked dopamine transporters and raised dopamine in the brain, also in the nucleus accumbens.11

The transporter also takes up toxins. MPP+, the active metabolite of the neurotoxin MPTP, is carried into dopamine neurons by the transporter, and MPTP causes a parkinsonian syndrome in humans and animals. A direct interaction between the transporter and the protein alpha-synuclein, which is implicated in Parkinson's disease, increased the transporter activity in cells and with it the toxicity of MPP+.8

Sources (11)
  1. Giros et al. 1992Giros B, el Mestikawy S, Godinot N, et al. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Mol Pharmacol
  2. Ciliax et al. 1995Ciliax BJ, Heilman C, Demchyshyn LL, et al. (1995) The dopamine transporter: immunochemical characterization and localization in brain J Neurosci
  3. Morón et al. 2002Morón JA, Brockington A, Wise RA, et al. (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines J Neurosci
  4. Ritz et al. 1987Ritz MC, Lamb RJ, Goldberg SR, et al. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine Science
  5. Volkow et al. 1997Volkow ND, Wang GJ, Fischman MW, et al. (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy Nature
  6. Sulzer 2011Sulzer D (2011) How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission Neuron
  7. Giros et al. 1996Giros B, Jaber M, Jones SR, et al. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature
  8. Torres et al. 2003Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function Nature Reviews Neuroscience
  9. Jones et al. 1998Jones SR, Gainetdinov RR, Wightman RM, et al. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter J Neurosci
  10. Sulzer et al. 1990Sulzer D, Rayport S (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action Neuron
  11. Volkow et al. 2009Volkow ND, Fowler JS, Logan J, et al. (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications JAMA

Binding affinity (Kᵢ)

21 substances, 32 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.

Human

18 measurements
  • α-PVP7.0 nMRickli et al. 2015
    Assay
    cloned DAT receptor or transporter binding (HEK293 cell membranes)
    Shown value from
    Rickli et al. 2015, Table 2
    Error
    ± 2.0 SD
  • MDPV19 nMEshleman et al. 2013 · 2 reports
    Assay
    HEK-293 cells expressing human DAT, [125I]RTI-55 displacement
    Shown value from
    Eshleman et al. 2013, Table 2
    Range
    10–19 nM in 2 reports
    Error
    ± 3.2 SEM, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 201310 nMTable 1
    Eshleman et al. 201319 nMTable 2
  • Methylphenidate60 nMHan et al. 2006
    Assay
    Uptake inhibition in Intestine 407 cells transiently expressing human DAT
    Shown value from
    Han et al. 2006, Table 1
    Error
    ± 10 SEM, n = 4
  • Diphenidine317 nMWallach et al. 2016
    Assay
    NIMH PDSP target-specific radioligand binding panel; secondary concentration-response assay after >50% inhibition at 10 µM
    Shown value from
    Wallach et al. 2016, Figure 2
  • Cocaineother reports differ494 nMEshleman et al. 2017 · 10 reports
    Assay
    [125I]RTI-55 radioligand binding inhibition at human DAT in HEK293 cells
    Shown value from
    Eshleman et al. 2017, Table 1
    Range
    164–595 nM in 10 reports
    Error
    ± 37 SEM, n = 29

    This is the best-supported value. Other reports differ. 12 reports in all, 140–595 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 2013280 nMTable 1
    Eshleman et al. 2017494 nMTable 1
    Eshleman et al. 2018595 nMTable 3
    Janowsky et al. 2014416 nMTable 4
    Eshleman et al. 2014462 nMTable 3
    Schmitt et al. 2011164 nMTable 1
    Andersen et al. 2015372 nMSupporting Table S3
    Eshleman et al. 2013558 nMTable 2
    Carroll et al. 2009272 nMTable 1
  • 6-APBAgonist600 nMRickli et al. 2015
    Assay
    cloned DAT receptor or transporter binding (HEK293 cell membranes)
    Shown value from
    Rickli et al. 2015, Table 2
    Error
    ± 50 SD
  • AmphetamineAgonistdepends on assay640 nMHan et al. 2006
    Assay
    Uptake inhibition in Intestine 407 cells transiently expressing human DAT
    Shown value from
    Han et al. 2006, Table 1
    Error
    ± 140 SEM, n = 4

    Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 640–5680 nM.

  • Bupropiondepends on assay810 nMAndersen et al. 2015 · 5 reports
    Assay
    COS-7 membranes expressing wild-type human DAT, [125I]beta-CIT competition binding
    Shown value from
    Andersen et al. 2015, Supporting Table S3
    Range
    320–871 nM in 5 reports
    Error
    ± 207 SEM, n = 3

    Values depend on the assay, species or conditions, and each is valid only for its own. 6 reports in all, 320–1236 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Schmitt et al. 2011320 nMTable 1
    Andersen et al. 2015810 nMSupporting Table S3
    Lapinsky et al. 2009441 nMTable 1
    Carroll et al. 2009871 nMTable 1
  • Butyloneunresolved1730 nMEshleman et al. 2013 · 2 reports
    Assay
    HEK-293 cells expressing human DAT, [125I]RTI-55 displacement
    Shown value from
    Eshleman et al. 2013, Table 2
    Range
    440–1730 nM in 2 reports
    Error
    ± 270 SEM, n = 7

    Reported values disagree and no value is established. 2 reports in all, 440–1730 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 2013440 nMTable 1
    Eshleman et al. 20131730 nMTable 2
  • IbogaineInhibitor1980 nMMash et al. 1995
    Assay
    human occipital cortex membranes, [125I]RTI-121 displacement
    Shown value from
    Mash et al. 1995, Results
    Error
    ± 460 SEM
  • Modafinil2143 nMSchmitt et al. 2011
    Assay
    intact stably transfected HEK293 cells expressing hDAT, [3H]CFT displacement
    Shown value from
    Schmitt et al. 2011, Table 1
    Error
    ± 215 SEM
  • 5-APBAgonist2600 nMRickli et al. 2015
    Assay
    cloned DAT receptor or transporter binding (HEK293 cell membranes)
    Shown value from
    Rickli et al. 2015, Table 2
    Error
    ± 300 SD
  • Methoxphenidine2915 nMWallach et al. 2016
    Assay
    NIMH PDSP target-specific radioligand binding panel; secondary concentration-response assay after >50% inhibition at 10 µM
    Shown value from
    Wallach et al. 2016, Figure 2
  • MethamphetamineAgonistother reports differ4580 nMEshleman et al. 2017 · 4 reports
    Assay
    [125I]RTI-55 radioligand binding inhibition at human DAT in HEK293 cells
    Shown value from
    Eshleman et al. 2017, Table 1
    Range
    1850–4750 nM in 4 reports
    Error
    ± 760 SEM, n = 23

    This is the best-supported value. Other reports differ. 5 reports in all, 460–4750 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 20131850 nMTable 1
    Eshleman et al. 20174580 nMTable 1
    Eshleman et al. 20144750 nMTable 3
    Eshleman et al. 20133960 nMTable 2
  • MephedroneAgonist4800 nMEshleman et al. 2013 · 2 reports
    Assay
    HEK-293 cells expressing human DAT, [125I]RTI-55 displacement
    Shown value from
    Eshleman et al. 2013, Table 2
    Range
    3400–4800 nM in 2 reports
    Error
    ± 750 SEM, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 20133400 nMTable 1
    Eshleman et al. 20134800 nMTable 2
  • MethyloneAgonist5020 nMEshleman et al. 2013 · 2 reports
    Assay
    HEK-293 cells expressing human DAT, [125I]RTI-55 displacement
    Shown value from
    Eshleman et al. 2013, Table 2
    Range
    2730–5020 nM in 2 reports
    Error
    ± 290 SEM, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 20132730 nMTable 1
    Eshleman et al. 20135020 nMTable 2
  • Psilocybin6077 nMGlatfelter et al. 2022
    Assay
    Transfected-cell radioligand binding at human DAT (UNC PDSP)
    Shown value from
    Glatfelter et al. 2022, Table S1
  • MDMAAgonist8290 nMHan et al. 2006
    Assay
    Uptake inhibition in Intestine 407 cells transiently expressing human DAT
    Shown value from
    Han et al. 2006, Table 1
    Error
    ± 1670 SEM, n = 4

Mouse

5 measurements
  • Methylphenidate260 nMHan et al. 2006
    Assay
    Uptake inhibition in Intestine 407 cells transiently expressing mouse DAT
    Shown value from
    Han et al. 2006, Table 1
    Error
    ± 30 SEM, n = 4
  • MethamphetamineAgonist470 nMHan et al. 2006
    Assay
    Uptake inhibition in Intestine 407 cells transiently expressing mouse DAT
    Shown value from
    Han et al. 2006, Table 1
    Error
    ± 80 SEM, n = 4
  • Cocaine490 nMHan et al. 2006
    Assay
    Uptake inhibition in Intestine 407 cells transiently expressing mouse DAT
    Shown value from
    Han et al. 2006, Table 1
    Error
    ± 40 SEM, n = 4
  • AmphetamineAgonist560 nMHan et al. 2006
    Assay
    Uptake inhibition in Intestine 407 cells transiently expressing mouse DAT
    Shown value from
    Han et al. 2006, Table 1
    Error
    ± 110 SEM, n = 4
  • MDMAAgonist4870 nMHan et al. 2006
    Assay
    Uptake inhibition in Intestine 407 cells transiently expressing mouse DAT
    Shown value from
    Han et al. 2006, Table 1
    Error
    ± 650 SEM, n = 4

Rat

5 measurements
  • Methylphenidate75 nMKim et al. 2007
    Assay
    rat striatal membranes, [3H]WIN 35,428 displacement
    Shown value from
    Kim et al. 2007, Table 1
    Error
    ± 7.4 SEM
  • MethamphetamineAgonist114 nMRothman et al. 2001
    Assay
    Rat caudate synaptosomes, [3H]dopamine uptake inhibition, 15 min at 25 °C
    Shown value from
    Rothman et al. 2001, Table V
    Error
    ± 11 SD, n = 3
  • Cocaine156 nMKim et al. 2007
    Assay
    rat striatal membranes, [3H]WIN 35,428 displacement
    Shown value from
    Kim et al. 2007, Table 1
    Error
    ± 11 SEM
  • MDMAAgonist1572 nMRothman et al. 2001
    Assay
    Rat caudate synaptosomes, [3H]dopamine uptake inhibition, 15 min at 25 °C
    Shown value from
    Rothman et al. 2001, Table V
    Error
    ± 59 SD, n = 3
  • EphedrineAgonist4398 nMRothman et al. 2001
    Assay
    Rat caudate synaptosomes, [3H]dopamine uptake inhibition, 15 min at 25 °C
    Shown value from
    Rothman et al. 2001, Table V
    Error
    ± 213 SD, n = 3

Unspecified

4 measurements
  • Methylphenidate110 nMFroimowitz et al. 2007
    Assay
    [125I]RTI-55 binding at the DAT
    Shown value from
    Froimowitz et al. 2007, Table 1
    Error
    ± 9.0 SEM
  • Ephenidine379 nMKang et al. 2017
    Assay
    NIMH PDSP radioligand binding, [3H]WIN35428 (0.5 nM), species not stated
    Shown value from
    Kang et al. 2017, Results (NIMH PDSP secondary assay, Table 1 not in the supplied PDF)
  • Cocaine500 nMFroimowitz et al. 2007
    Assay
    [125I]RTI-55 binding at the DAT
    Shown value from
    Froimowitz et al. 2007, Table 1
    Error
    ± 65 SEM
  • 3-MeO-PCE743 nMRoth BryanL et al. 2018
    Assay
    NIMH PDSP radioligand binding, DAT
    Shown value from
    Roth BryanL et al. 2018, Corrected Supplementary Table S1

Functional potency (EC₅₀)

13 substances, 18 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.

Human

5 measurements
  • MethamphetamineAgonistother reports differ435 nMEshleman et al. 2017 · 4 reports
    Assay
    Release of preloaded [3H]neurotransmitter from HEK293 cells expressing human DAT
    Shown value from
    Eshleman et al. 2017, Table 3
    Range
    400–1560 nM in 4 reports
    Error
    ± 74 SEM, n = 13
    Emax
    101.3 ± 2.9%

    This is the best-supported value. Other reports differ. 4 reports in all, 400–1560 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 20131560 nMTable 3
    Eshleman et al. 2017435 nMTable 3
    Eshleman et al. 2014970 nMTable 3
    Eshleman et al. 2013400 nMTable 3
  • MephedroneAgonistunresolved1190 nMEshleman et al. 2013 · 2 reports
    Assay
    HEK-293 cells expressing human DAT, release of preloaded [3H]dopamine
    Shown value from
    Eshleman et al. 2013, Table 3
    Range
    1190–3750 nM in 2 reports
    Error
    ± 340 SEM, n = 5
    Emax
    68.0 ± 11.0%

    Reported values disagree and no value is established. 2 reports in all, 1190–3750 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 20133750 nMTable 3
    Eshleman et al. 20131190 nMTable 3
  • AmphetamineAgonist1760 nMSimmler et al. 2013
    Assay
    Monoamine release from preloaded HEK293 cells overexpressing human DAT
    Shown value from
    Simmler et al. 2013, Table 3
  • CathinoneAgonist5640 nMSimmler et al. 2013
    Assay
    Monoamine release from preloaded HEK293 cells overexpressing human DAT
    Shown value from
    Simmler et al. 2013, Table 3
  • MDMAAgonist7500 nMEshleman et al. 2017 · 2 reports
    Assay
    Release of preloaded [3H]neurotransmitter from HEK293 cells expressing human DAT
    Shown value from
    Eshleman et al. 2017, Table 3
    Range
    4800–7500 nM in 2 reports
    Error
    ± 2300 SEM, n = 10
    Emax
    94.0 ± 10.0%
    Sources and values behind the range, same assay family
    ReportValueWhere
    Eshleman et al. 20177500 nMTable 3
    Eshleman et al. 20134800 nMTable 3

Rat

13 measurements

Also reported to act here

Substances reported to act here, without a displayed value.

Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.